|
|
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands |
Carrion Salip, Dolors
; Panosa Roqueta, Clara
; Menéndez Menéndez, Javier Abel
; Puig, Teresa
; Oliveras, Glòria
; Pandiella, Atanasio
; Llorens Duran, Rafael de
; Massaguer i Vall-llovera, Anna
|
|
|
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands |
Carrion Salip, Dolors
; Panosa Roqueta, Clara
; Menéndez Menéndez, Javier Abel
; Puig, Teresa
; Oliveras, Glòria
; Pandiella, Atanasio
; Llorens Duran, Rafael de
; Massaguer i Vall-llovera, Anna
|
|
5 juny 2018 |
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands |
Carrion Salip, Dolors
; Panosa Roqueta, Clara
; Menéndez Menéndez, Javier Abel
; Puig, Teresa
; Oliveras, Glòria
; Pandiella, Atanasio
; Llorens Duran, Rafael de
; Massaguer i Vall-llovera, Anna
|
|
2012 |
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands |
Carrion Salip, Dolors
; Panosa Roqueta, Clara
; Menéndez Menéndez, Javier Abel
; Puig i Miquel, Teresa
; Oliveras, Glòria
; Pandiella, Atanasio
; Llorens Duran, Rafael de
; Massaguer i Vall-llovera, Anna
|
|
22 maig 2015 |
Bioenergetics mechanism and autophagy in breast cancer stem cells |
Cufà González, SÃlvia
|
|
|
Bioenergetics mechanism and autophagy in breast cancer stem cells |
Cufà González, SÃlvia
|
|
2017 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
5 juny 2018 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
11 desembre 2008 |
Els Efectes biològics de l’oli d’oliva sobre la salut de les persones (II) |
Menéndez, Javier
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
5 juny 2018 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
2011 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz Duran, Maria Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
abril 2012 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
5 juny 2018 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
21 juny 2013 |
Nous mecanismes de resistència primà ria al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de cà ncer de mama (Basal/ErbB2+) |
Oliveras Ferrarós, Cristina
|
|
|
Nous mecanismes de resistència primà ria al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de cà ncer de mama (Basal/ErbB2+) |
Oliveras Ferrarós, Cristina
|
|
2014 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
5 juny 2018 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|